| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 110 | 103 | 2,467 | 3,500 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 110 | 103 | 2,467 | 3,500 | | | Operating Expenses | | Research Development | 310 | 716 | 602 | 1,270 | | Selling General and Administrative | 714 | 695 | 1,091 | 1,897 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (914) | (1,309) | 773 | 334 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 72 | | Earnings Before Interest And Taxes | (1,397) | (1,309) | 773 | 406 | | Interest Expense | (206) | 118 | 88 | 203 | | Income Before Tax | (1,191) | (1,426) | 685 | 202 | | Income Tax Expense |
-
|
-
|
-
| (938) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,191) | (1,426) | 685 | 1,140 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,191) | (1,426) | 685 | 1,140 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,191) | ($1,426) | $685 | $1,140 |
|
1.23% Nasdaq 0.00%
Income Statement
